Institutional investors purchased a net $3.3 million shares of SCLN during the quarter ended June 2015. This may signal that the smart money is gaining interest in this company as the 82.74% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SSGA FUNDS MANAGEMENT, INC. Bought 921.2 Thousand shares of SciClone Pharmaceuticals ...